NCT05498389 2023-06-01
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 1/2 Unknown
Clinical Trials
5 trialsNCT05513664 2022-08-24
Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc.
Unknown
NCT05284994 2022-03-17
TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Unknown
NCT05132777 2021-11-24
Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc.
Phase 2 Unknown
NCT04448379 2020-12-28
Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc.
Phase 1 Unknown